ArticleFrontiers in aging neuroscience2023
Identifying Alzheimer's disease and mild cognitive impairment with atlas-based multi-modal metrics.
Article in Frontiers in aging neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- From Single-Modal to Multi-Modal Artificial Intelligence in Alzheimer's Disease: A Systematic Review of Databases, Modalities, Diagnostic Performance, and Clinical Translation Challenges.Sensors (Basel, Switzerland) · 2026Pooled it
- The application value of Rs-fMRI-based machine learning models for differentiating mild cognitive impairment from Alzheimer's disease: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Pooled it
- Machine Learning Driven by Magnetic Resonance Imaging for the Classification of Alzheimer Disease Progression: Systematic Review and Meta-Analysis.JMIR aging · 2024Pooled it
- Frontiers and hotspots evolution in mild cognitive impairment: a bibliometric analysis of from 2013 to 2023.Frontiers in neuroscience · 2024Pooled it
- Rs-fMRI reveals that taVNS improves cognitive and emotional function in mild cognitive impairment by reconfiguration of "sensory relay-salience-default" cross-network effective connectivity: a randomized, double-blind, sham-controlled trial.Frontiers in neurology · 2026Trial
- Multimodal MRI insights into hippocampal pathological changes across the Alzheimer's disease continuum: advances and challenges.Japanese journal of radiology · 2026Review
- AI-Enabled Modeling for Alzheimer's Disease Risk Prediction and Validation.Revista de neurologia · 2026Article
- Electroencephalography for early Alzheimer's disease diagnosis: from advanced feature engineering to interpretable ai and clinical translation.Frontiers in psychiatry · 2026Review
- Artificial neural networks fighting real neural decline: a systematic review of AI in Alzheimer's research.Artificial intelligence review · 2026Article
- Association of reported sleep disturbances with objectively assessed mild cognitive impairment among adults in the United States.SAGE open medicine · 2025Article
- Multidimensional digital biomarker phenotypes for mild cognitive impairment: considerations for early identification, diagnosis and monitoring.Frontiers in digital health · 2024Article
- Correlation transfer function analysis as a biomarker for Alzheimer brain plasticity using longitudinal resting-state fMRI data.Scientific reports · 2023Article
- Resting-state MEG of whole-brain functional network in cingulate gyrus epilepsy.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Multi-modal neuroimaging metrics in combination with advanced machine learning techniques have attracted more and more attention for an effective multi-class identification of Alzheimer's disease (AD), mild cognitive impairment (MCI) and health controls (HC) recently. Methods: In this paper, a total of 180 subjects consisting of 44 AD, 66 MCI and 58 HC subjects were enrolled, and the multi-modalities of the resting-state functional magnetic resonance imaging (rs-fMRI) and the structural MRI (sMRI) for all participants were obtained. Then, four kinds of metrics including the Hurst exponent (HE) metric and bilateral hippocampus seed independently based connectivity metrics generated from fMRI data, and the gray matter volume (GMV) metric obtained from sMRI data, were calculated and extracted in each region of interest (ROI) based on a newly proposed automated anatomical Labeling (AAL3) atlas after data pre-processing. Next, these metrics were selected with a minimal redundancy maximal relevance (MRMR) method and a sequential feature collection (SFC) algorithm, and only a subset of optimal features were retained after this step. Finally, the support vector machine (SVM) based classification methods and artificial neural network (ANN) algorithm were utilized to identify the multi-class of AD, MCI and HC subjects in single modal and multi-modal metrics respectively, and a nested ten-fold cross-validation was utilized to estimate the final classification performance. Results: The results of the SVM and ANN based methods indicated the best accuracies of 80.36 and 74.40%, respectively, by utilizing all the multi-modal metrics, and the optimal accuracies for AD, MCI and HC were 79.55, 78.79 and 82.76%, respectively, in the SVM based method. In contrast, when using single modal metric, the SVM based method obtained a best accuracy of 72.62% with the HE metric, and the accuracies for AD, MCI and HC subjects were just 56.82, 80.30 and 75.86%, respectively. Moreover, the overlapping abnormal brain regions detected by multi-modal metrics were mainly located at posterior cingulate gyrus, superior frontal gyrus and cuneus. Conclusion: Taken together, the SVM based method with multi-modal metrics could provide effective diagnostic information for identifying AD, MCI and HC subjects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.